FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/01/049059 [Registered on: 17/01/2023] Trial Registered Prospectively
Last Modified On: 02/01/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Screening 
Study Design  Other 
Public Title of Study   Management of Insomnia by Ayurvedic Errhine Therapy 
Scientific Title of Study   Evaluation of Comparative Efficacy of Shankapushpi Taila Nasya versus ksheerbala Taila Nasya in the Management of Anidra Primary Insomnia Randomized Controlled Trial 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Annya Satish Kumar Sharma Gautam 
Designation  PG Scholar 
Affiliation  Datta Meghe Institute of Medical Sciences Wardha 
Address  Room no 40 Department of Pachakarma Mahatma Gandhi Ayurved College Hospital and Research Centre Salod Wardha

Wardha
MAHARASHTRA
442001
India 
Phone  8218406491  
Fax    
Email  ananyagautam68@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Annya Satish Kumar Sharma Gautam 
Designation  PG Scholar 
Affiliation  Datta Meghe Institute of Medical Sciences Wardha 
Address  Room no 40 Department of Pachakarma Mahatma Gandhi Ayurved College Hospital and Research Centre Salod Wardha

Wardha
MAHARASHTRA
442001
India 
Phone  8218406491  
Fax    
Email  ananyagautam68@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Vinod Ade 
Designation  Professor 
Affiliation  Datta Meghe Institute of Medical Sciences Wardha 
Address  Room no 40 Department of Pachakarma Mahatma Gandhi Ayurved College Hospital and Research Centre Salod Wardha

Wardha
MAHARASHTRA
442001
India 
Phone  9689365368  
Fax    
Email  dr.vinodade@gmail.com  
 
Source of Monetary or Material Support  
Mahatma Gandhi Ayurved College Hospital And Reaearch centre 
 
Primary Sponsor  
Name  Mahatma Gandhi Ayurved College Hospital And Research Centre 
Address  Room no 40 Department of Pachakarma Mahatma Gandhi Ayurved College Hospital and Research Centre Salod Wardha 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Annya Gautam  Mahatma Gandhi Ayurved College Hospital and Research Centre   Room no 40 Department of Panchakarma Salod Hirapur Wardha
Wardha
MAHARASHTRA 
8218406491

ananyagautam68@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Mahatma Gandhi Ayurved College Hospital And Research Centre Institutional Ethics Committee Salod Wardha  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:F99||Mental disorder, not otherwise specified. Ayurveda Condition: NIDRANASAH/ASVAPNAH, (2) ICD-10 Condition:G||Mental Health. Ayurveda Condition: NIDRANASAH/ASVAPNAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Ksheerabala, Reference: Bhaishajya ratnavali, Route: Nasal, Dosage Form: Taila, Dose: 8(drops), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 15 Days, anupAna/sahapAna: No, Additional Information: only observing the efficacy of Khseerabala taila not Nasya procedure
2Intervention ArmDrugClassical(1) Medicine Name: Shankhapushpi, Reference: Kaidev Nighantu, Route: Nasal, Dosage Form: Taila, Dose: 8(drops), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 15 Days, anupAna/sahapAna: No, Additional Information: only observing the efficacy of Shankhapushpitaila not Nasya procedure
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Patients who are willing to give written inform consent
2.Patients either gender age between 20 to 60 years
3.Patients who are fit for Nasyakarma
4.Patient with controlled hypertension
5.ICD10 criteria for primary insomnia F51 point 01 
 
ExclusionCriteria 
Details  1.Patients less than 20 years and more than 60 years
2.Pregnant women and lactating mothers
3.Patient with co morbidities Example uncontrolled Hypertension DM2 Thyroids and Cardiac disorders
4.Patient not fit for Nasya karma Pratishyaya Trushna Ajirna Rajaswala etc
5.Patient with drug dependency like Anti histamines Narcotics
6.Occupational disorder 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
To assess the efficacy of Shankhapushpi Taila and Ksheerabala Taila in Pitssburg Sleep Quality Index Insomnia severity index and Quality of life  15 days 
 
Secondary Outcome  
Outcome  TimePoints 
To assess the efficacy of Shankhapushpi Taila and Ksheerabala Taila in Pitssburg Sleep Quality Index Insomnia severity index and Quality of life  0 day 15th day 30th day 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   31/01/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  31/01/2023 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   the volunteer will be inform about the study protocol willing participants will be randomly selected as per computer generated table. clinical research format will be prepared and validated prior to the study approval will be taken from IEC,MGACHRC, Salod (hirapur), wardha and CTRI registration will be done. After selection, each participants will be tested individually and selected according to selection criteria. they are divided into two groups the trial is parallel group, randomized, single blind clinical, standard controlled trial. it will include 15 days treatment period and 16th and 30th day follow up period. 
Close